Dual Antiplatelet Therapy Beyond 1 Year Postinfarction: The Time Has Come and We're Beginning to Know Who Will Benefit
Rev Esp Cardiol (Engl Ed). 2016 May;69(5):471-3.
doi: 10.1016/j.rec.2016.01.020.
Epub 2016 Mar 31.
[Article in
English,
Spanish]
Affiliation
- 1 Unidad de Hemodinámica y Cardiología Intervencionista, Servicio de Cardiología, Hospital General Universitario de Alicante, Alicante, Spain. Electronic address: ruiz_jmi@gva.es.
No abstract available
MeSH terms
-
Acute Coronary Syndrome / drug therapy*
-
Adenosine / administration & dosage
-
Adenosine / analogs & derivatives
-
Aspirin / administration & dosage
-
Clopidogrel
-
Drug Therapy, Combination
-
Humans
-
Myocardial Infarction / drug therapy*
-
Patient Selection
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Prasugrel Hydrochloride / administration & dosage
-
Secondary Prevention
-
Ticagrelor
-
Ticlopidine / administration & dosage
-
Ticlopidine / analogs & derivatives
-
Time Factors
Substances
-
Platelet Aggregation Inhibitors
-
Clopidogrel
-
Prasugrel Hydrochloride
-
Ticagrelor
-
Adenosine
-
Ticlopidine
-
Aspirin